ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Genfit

Genfit (XUP)

3.595
-0.035
(-0.96%)
Closed 06 January 8:00AM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.595
Bid
3.57
Offer
3.62
Volume
2,801
3.575 Day's Range 3.575
3.06 52 Week Range 5.77
Previous Close
3.63
Open
3.575
Last Trade
166
@
3.575
Last Trade Time
Average Volume (3m)
975
Financial Volume
-
VWAP
-

XUP Latest News

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone...

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July...

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive Lille (France), Cambridge (Massachusetts...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.12.861230329043.4953.593.4954403.545DE
4-0.095-2.574525745263.693.733.4157953.54550915DE
12-1.795-33.30241187385.395.773.4159754.52628818DE
26-0.135-3.619302949063.735.773.41512644.41685471DE
52-0.225-5.890052356023.825.773.0614054.26713183DE
1560.092.567760342373.5055.772.85514104.02964341DE
2600.092.567760342373.5055.772.85514104.02964341DE

XUP - Frequently Asked Questions (FAQ)

What is the current Genfit share price?
The current share price of Genfit is 3.595 €
What is the 1 year trading range for Genfit share price?
Genfit has traded in the range of 3.06 € to 5.77 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0S6Cerence Inc
18.972 €
(145.34%)
89.94k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
2WOWide Open Agriculture Ltd
0.005 €
(-23.08%)
50k
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discussion

View Full Feed
HokieHead HokieHead 5 minutes ago
Canada markets require more paperwork, according to management I spoke to their counsel will continue starting Monday to fulfill all requests, above what was already submitted. You can tell the naked shorts are not happy with what’s about to happen to their air shares. Huge gap and run incoming.
TWOH
All City Baby All City Baby 6 minutes ago
Okay, that makes me feel better. That link I found by Googling. I just assumed you could navigate to it through the website, but I tried after reading your post and it doesn't seem as though you can. The URL itself should just be eliminated but at least it's not something you can access from the web
RSPI
flipper44 flipper44 7 minutes ago
A lot to unpack, but one thing you stated I do agree with is that NWBO should not hide any balls at (likely) approval.
NWBO
GoodGuyBill GoodGuyBill 7 minutes ago
WE ARE NOT SELLING FOR $1!!!!!!!!!!
NWBO
HokieHead HokieHead 8 minutes ago
Nothing is wrong, have you contacted old or new TWOH management? I guess that’s not part of the agenda lol.
TWOH
StockItOut StockItOut 8 minutes ago
Xeriant's stating a different reason for the same claim.
New attorney, different legal approach.
Maybe you'll catch up.
XERI
3331 3331 9 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
HokieHead HokieHead 9 minutes ago
So glad I don’t have a huge naked short position here 😢..
TWOH
joyceschoice joyceschoice 10 minutes ago
I know that history. I've read the books. And guess what JPM is still cooking and GS too. You should look at some of my really early posts where Just Plain Monstrous showed up. I've been here decades. Don't preach to me please. Here we are. I'm waiting for the end game. So why do you guys th
JPM
silvr_surfr silvr_surfr 11 minutes ago
Thanks JTFM. So here's something strange. When I go to the ANIP website, the product section has changed. It is now geared towards medical professionals only and, importantly, only lists the three rare disease products. Is this a tip of the hand which means the surviving ANIP entity will be.a ra
ANIP
HokieHead HokieHead 11 minutes ago
Phone numbers are readily available lol. It’s easy. But wait that’s not a smart thing for naked shorts to do.

What a hoot!
TWOH
HokieHead HokieHead 12 minutes ago
Would suck for the naked shorts when this gaps up to match the CSE prices huh, glad I don’t have a huge naked short position, lmfao.
TWOH
3331 3331 13 minutes ago
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med
umustlikedat umustlikedat 13 minutes ago
Great post
FNMA
HappyAlways HappyAlways 14 minutes ago
Many funds are not allowed to invest in OTC stocks. Uplist will certainly help. IMO.
FNMA
HokieHead HokieHead 14 minutes ago
Wrong, maybe it would help to contact both old and new TWOH management before spreading falsehoods. Obviously didn’t work at other tickers. Lmao.
TWOH
Polymer Paul Polymer Paul 14 minutes ago
I asked chat smith GPT ...why did Dr lebby leave lightwave logic? Is it because he messed deals up?........

Dr. Lebby left Lightwave Logic, where he served as CEO, due to a combination of strategic differences and personal choices regarding the company's direction. While there were ch
LWLG
Zorax Zorax 14 minutes ago
That's interesting and I hope it is solved for you.
Keep trying to find a pattern. Any change in meds in the last two days?
dstock07734 dstock07734 15 minutes ago
The shorts must be desperate to such an extent that they really didn't think it over before bringing you back. The fact that you come back is a bullish sign. No one believes your BS.
NWBO
dragoon76 dragoon76 15 minutes ago
Seriously though...what is your purpose being here? You and your crew repeatedly tell us that nothing is coming back. Why? What's the logic in that if none of us have any control over the situation...OR DO WE and we just don't know it, yet?
COOP
OMOLIVES OMOLIVES 16 minutes ago
You should really stop with the Adverts' man. EOM
Nick2424 Nick2424 16 minutes ago
What happened to the expected California composting contracts expected by end of 2024? You need to talk about it. Just another reason for investors to lose trust if you don't.

Why are there weekly meetings with the PR team. Why don't they start doing stuff to make the stock go up. Do
DUTV
boston745 boston745 17 minutes ago
In the post referenced at the end of this post, i say i think i understand what Musks role is for the DoD & intelligence community. However after watching a show called Salvation again, i picked up on something i hadnt noticed before. Before i get into that, here is a quote from that post:
HokieHead HokieHead 18 minutes ago
Lmfao, keep watching.
TWOH
ron_66271 ron_66271 19 minutes ago
Your Statement Makes No Sense.

“Link where anyone else shows that JPM failed because of Lehman.”

JPM didn’t fail because of Lehman’s.

JPM failed because JPM wrote more Derivative Contracts than JPM could cover.
Hint; Bears Sterns.

JP
JPM

Your Recent History

Delayed Upgrade Clock